---
title: Biologics (Monoclonal Antibodies) CDMOs in India
path: /modalities/biologics-monoclonal-antibodies/india
companies_count: 8
---

# Biologics (Monoclonal Antibodies) CDMOs in India

8 published CDMOs match Biologics (Monoclonal Antibodies) in India.

Locations in this set include India, United States, Australia, France, Germany, and Italy.

Capabilities that show up most often in this set: Stability Testing & Storage, CMC Analytical Development, Biologics Development & Manufacturing, Process Development, and Quality Control Testing.

## Matching companies

- [Aurobindo Pharma CDMO](/companies/aurobindo)
  - Aurobindo Pharma Limited is one of the largest generic pharmaceutical companies globally, with a strong commitment to making medicines affordable and accessible.
- [Biocon](/companies/biocon)
  - Fully integrated biopharmaceutical company developing affordable biosimilars, generic formulations, and complex APIs for diabetes, cancer, and autoimmune diseases.
- [Curia](/companies/curiaglobal)
  - Global CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India.
- [Dr. Reddy's Laboratories](/companies/drreddys)
  - Integrated global pharmaceutical company manufacturing generics, APIs, biosimilars, and innovative medicines across 66 countries with capabilities in small molecule and biologics development and manufacturing.
- [Enzene Biosciences](/companies/enzene)
  - Global CDMO specializing in cost-effective biologics and biosimilars manufacturing using patented continuous bioprocess technology (EnzeneX®). Offers integrated drug discovery, development, and manufacturing services with facilities in India and expanding presence in the USA and Europe.
- [Lupin Limited](/companies/lupin)
  - Global pharmaceutical manufacturer with robust quality systems aligned to US FDA, UK MHRA, and EU GMP standards; operates diversified manufacturing across generics, complex formulations, and specialty segments with advanced automation and digital quality infrastructure.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [Yapan Bio](/companies/yapan-bio)
  - Yapan Bio provides integrated process development, characterization, and GMP manufacturing for vaccines, monoclonal antibodies, gene therapy, and viral vector-based biologics, with capabilities up to 1000L bioreactor scale and BSL-2+ containment.